Discontinued — last reported Q2 '15
An increase suggests rising legal risks or the resolution of historical litigation, which can negatively impact cash reserves and investor sentiment.
This metric tracks expenses or reserves specifically allocated to legal claims, product liability litigation, or regulat...
Similar to 'Legal Reserves' or 'Litigation-related Charges' reported by other medical device and pharmaceutical firms facing product liability exposure.
zbh_segment_material_reconciling_items_certain_claims